Last reviewed · How we verify

naproxen sodium codein

Diskapi Yildirim Beyazit Education and Research Hospital · FDA-approved active Small molecule

Naproxen sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, while codeine acts as an opioid agonist to provide additional analgesic and antitussive effects.

Naproxen sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, while codeine acts as an opioid agonist to provide additional analgesic and antitussive effects. Used for Moderate to severe acute pain, Chronic pain conditions.

At a glance

Generic namenaproxen sodium codein
Also known asApranax plus
SponsorDiskapi Yildirim Beyazit Education and Research Hospital
Drug classNSAID + opioid combination analgesic
TargetCOX-1, COX-2, mu opioid receptor
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that blocks COX-1 and COX-2 enzymes, reducing inflammation, pain, and fever. Codeine is an opioid analgesic and antitussive that binds to mu opioid receptors in the central nervous system. The combination provides enhanced pain relief through dual mechanisms—peripheral anti-inflammatory action and central opioid analgesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results